Concepedia

Sheng-Te Wang

SW

Statistics

Publications

7

Citations

262

H-Index

7

Active since

2019

Affiliations

Jinan University(Current)

St. John's University

First Affiliated Hospital of Wenzhou Medical University

Wenzhou Medical University

Guangzhou Medical University

Sheng-Te Wang is an author at Jinan University specializing in oncology, molecular oncology, and medicine.

Publications per year

2019–2023

7

Publications

7

Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer

Haihong Zhou, Chen Xu, Luya Cai et al. · Frontiers in Oncology · 2019 · 135 citations · Full text

, , +17

Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance

Kun Wang, Zihao Xing, Qiwei Jiang et al. · Frontiers in Oncology · 2019 · 49 citations · Full text

, , +14

Piperlongumine Alleviates Mouse Colitis and Colitis-Associated Colorectal Cancer

Jia-Rong Huang, Sheng-Te Wang, Meng-Ning Wei et al. · Frontiers in Pharmacology · 2020 · 21 citations · Full text

, , +16

Survivin Promotes Piperlongumine Resistance in Ovarian Cancer

Xing-Wei Nan, Li-Hua Gong, Xu Chen et al. · Frontiers in Oncology · 2019 · 17 citations · Full text

, , +17

GLUL stabilizes N-Cadherin by antagonizing β-Catenin to inhibit the progresses of gastric cancer

Qiwei Jiang, Yong Li, Songwang Cai et al. · Acta Pharmaceutica Sinica B · 2023 · 17 citations · Full text

, , +17

1–5 of 7